bimekizumab,Adalimumab
ucb pharmaceuticals,abbvie
['axspa', 'spondylitis', 'consortium', 'be complete', 'psoriasis', 'bimekizumab', 'be optimal', ' psa', 'psoriatic arthritis', 'be mobile', 'emergent ']
$ucb.bb ucb new long-term data on bimekizumab in psoriatic arthritis and axial spondyloarthritis presented at eular 2023 